Celgene

Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Alnylam
Regulus
Isis Pharmaceuticals
SynaGeva BioPharma
Sarepta Therapeutics
Onyx
Celgene
Millennium
Takeda
Ariad Pharmaceuticals
Pharmacyclics
Astex
Banking on Biotech
CNBC
Sat, 01/12/13 - 10:33 am
Regeneron
Biogen Idec
Acorda Therapeutics
Sanofi
Celgene
Alexion
Biomarin
NPS Pharmaceuticals
Cerner
EXACT Sciences
Pfizer
Bristol-Myers Squibb
Eli Lilly
Celgene Most Impressive On Day 1 of J.P. Morgan Healthcare Confab
TheStreet.com
Tue, 01/8/13 - 10:31 am
Celgene
JPMHC 2013
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville
Thu, 12/27/12 - 10:16 pm
Rytary
GSK
Impax Labs
Celgene
pomalidomide
Roche
T-DM1
Immunogen
Eliquis
Pfizer
Bristol-Myers Squibb
Biogen Idec
BG-12
Is Celgene in Good Hands?
Motley Fool
Thu, 12/27/12 - 07:59 am
Celgene
Celgene inks $500M-plus deal with ADC developer Sutro
Fierce Pharma
Wed, 12/19/12 - 01:35 pm
Celgene
Sutro
Celgene Investors: What to Watch
Motley Fool
Sun, 12/16/12 - 10:19 am
Celgene
pomalidomide
Multiple Myeloma
Celgene's Momentum Continues
Motley Fool
Wed, 12/12/12 - 08:06 am
Celgene
pomalidomide
Multiple Myeloma
Celgene’s Pomalidomide Helps in Myeloma After Others Fail
Bloomberg
Tue, 12/11/12 - 10:22 am
Celgene
pomalidomide
ONYX Pharmaceuticals
Multiple Myeloma
7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013
Seeking Alpha
Fri, 12/7/12 - 11:45 am
Alexza
BiogenIdec
Celsion
Celgene
Sanofi
JNJ
Threshold Pharmaceuticals
Upcoming AML Treatments - Which Company Will Fly?
Seeking Alpha
Mon, 12/3/12 - 10:49 am
AML
Celgene
Cyclacel
Sunesis
acute myeloid leukemia
Celgene Corporatio: Today's Featured Drugs Laggard
The Street
Sat, 12/1/12 - 09:21 am
Celgene
Celgene, NPS Pharmaceuticals, Amarin, J&J, Medivation Among Stocks to Watch in December
Minyanville
Fri, 11/30/12 - 04:28 pm
NPS Pharmaceuticals
Medivation
JNJ
Celgene
Amarin
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Motley Fool
Thu, 11/29/12 - 11:05 am
Revlimid
Celgene
Vidaza
Abraxane
apremilast
pomalidomide
Amarin Is Really Good At Delays, Drug Launches Not So Much
TheStreet.com
Thu, 11/29/12 - 10:42 am
Amarin
Vascepa
drug launches
Celgene
Sanofi
Celgene, Sanofi Executives Charged With Insider Trading
Wed, 11/21/12 - 02:17 pm
Celgene
Sanofi
Management
legal
insider trading
stock
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Mon, 11/19/12 - 02:00 pm
Oncothyreon
Celsion
Arena Pharmaceuticals
NuPathe
Hemispherx
Amarin
Biogen Idec
Gilead
Hyperion Therapeutics
Celgene
Raptor Pharmaceuticals
Dynavax
Zogenix
Impax Labs
Celgene's Lazorchak, Five Others, Charged With Insider Trading
Yahoo/Bloomberg
Mon, 11/19/12 - 01:55 pm
insider trading
Celgene
Abraxane Cancer Trials Help Justify Celgene Buyout
investors.com
Sat, 11/17/12 - 02:03 pm
Abraxane
Celgene
pancreatic cancer

Pages